| Not Yet Recruiting | Phase II Study of Ficerafusp Alfa in Combination With Nivolumab in Patients With Platinum-refractory Head and Squamous Cell Carcinoma of Head and Neck (SCCHN) | Phase 2 | 2026-05-01 |
| Not Yet Recruiting | Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) | Phase 3 | 2026-04-01 |
| Recruiting | Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pu Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 2 | 2025-10-13 |
| Recruiting | Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squa Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck | Phase 2 | 2025-01-02 |
| Terminated | Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Can Squamous Cell Carcinoma of the Head and Neck | Phase 3 | 2023-12-12 |
| Terminated | Study of OBT076 Associated or Not in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Hea Adenoid Cystic Carcinoma of the Head and Neck | Phase 1 | 2023-11-29 |
| Completed | Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma Cancer of Head and Neck | Phase 2 | 2021-02-04 |
| Active Not Recruiting | Trial Evaluating the Tolerance and Safety of Durvalumab - RT Combination for Treatment in SCCHN HNSCC | Phase 2 | 2019-07-17 |
| Active Not Recruiting | A Trial Evaluating the Addition of Nivolumab to Cisplatin-RT for Treatment of Cancers of the Head and Neck Squamous Cell Carcinoma of Head and Neck | Phase 3 | 2018-10-10 |
| Active Not Recruiting | Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH) HNSCC | Phase 3 | 2017-09-14 |
| Active Not Recruiting | Chemo-radiotherapy Versus Radiotherapy in the Treatment of Salivary Glands and Nasal Tumors (IMRT or Protonthe HNSCC | Phase 3 | 2017-01-20 |
| Completed | Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2016-05-18 |
| Completed | Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion Squamous Cell Carcinoma of the Head and Neck | Phase 2 | 2015-12-03 |
| Active Not Recruiting | Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC Head and Neck Squamous Cell Carcinoma | Phase 2 | 2015-09-21 |
| Active Not Recruiting | Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT Head and Neck Squamous Cell Carcinoma | Phase 3 | 2015-06-25 |
| Completed | Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC Head and Neck Squamous Cell Carcinoma | Phase 2 | 2014-10-10 |
| Completed | Evaluation of the Tolerance of Afatinib in Combination With Docetaxel and Cisplatin in LAHNSCC Induction Chemo HNSCC | Phase 1 | 2014-08-06 |
| Completed | Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With Head and Neck Squamous Cell Carcinoma | Phase 3 | 2013-10-18 |
| Completed | Phase II Trial of Carboplatin, 5-FU and Cetuximab in Elderly Fit (no Frailty) Patients With Recurrent/Metastat Metastatic or Recurrent Head and Neck Squamous Cell Cancer | Phase 2 | 2013-09-01 |
| Completed | Reirradiation and Erbitux in the HNSCC Head and Neck Cancer Squamous Cell | Phase 2 | 2010-10-01 |
| Completed | Trial of OTD70DERM® in Radio-dermatitis Induced by Radiotherapy-Erbitux® Head and Neck Carcinoma | Phase 3 | 2010-08-01 |
| Completed | Hematologic Toxicity Observation of the Docetaxel+ Cisplatin+ Fluorouracil (TPF)Medical Protocol Squamous Cell Head and Neck Carcinoma | — | 2010-06-01 |
| Completed | Chemotherapy With Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Squamous Cell Head and Neck Carcinoma, Recurrent or Metastatic Disease | Phase 2 | 2009-09-01 |
| Completed | Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux. Squamous Cell Head and Neck Carcinoma | Phase 3 | 2009-05-18 |
| Terminated | Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers Nasopharyngeal Cancers | Phase 3 | 2009-01-01 |
| Completed | Randomized Trial of Concomitant Chemotherapy in Patients With Locally Advanced HNSCC Treated by Radiotherapy-e HNSCC | Phase 3 | 2008-02-15 |
| Completed | Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preserv Larynx Cancer, Hypopharynx Cancer | Phase 2 | 2005-10-01 |
| Completed | IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC Oral Cancer, Oropharynx Cancer, Hypopharynx Cancer | Phase 3 | 2005-09-27 |
| Terminated | Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Ca Head and Neck Cancer | Phase 2 | 2005-09-01 |
| Completed | Induction CT by Cisplatin, 5FU With or Without Docetaxel in Patients With T3 and T4 Larynx and Hypopharynx Car Larynx Cancer, Hypopharynx Cancer | Phase 3 | 2001-12-15 |
| Completed | Intravenous Versus Subcutaneous Amifostine in Prevention of Xerostomia After RT for Head and Neck Carcinomas Head and Neck Cancer | Phase 3 | 2001-03-01 |
| Completed | Accelerated Radiotherapy and Concomitant Chemo-radiotherapy in HNSCC Oral Cancer, Oropharynx Cancer, Hypopharynx Cancer | Phase 3 | 2000-03-01 |